Patient Journey Scope Estimator

60% of drug launches miss year-1 forecasts. Most never recover.

Know what your patients are going through. Before launch.

Most launches are built on assumptions. Survey data, HCP panels, synthetic personas. None of them tell you what patients actually experience. This estimator scopes the patient intelligence your launch needs, mapped to your disease areas and markets.

What you’ll get

Five dimensions of patient intelligence for launch decisions.

Diagnosis journey

Time-to-diagnosis, misdiagnosis rates, and the triggers that finally push patients toward care.

Referral pathways

Which specialists drive diagnosis in your markets — and whether your field team is reaching them.

Treatment journey

Line of therapy, adherence patterns, and discontinuation reasons — in patients' own words.

Daily life impacts

Functional and emotional burden — what patients need from treatment beyond what trials measure.

Unmet needs

What patients say is missing from their care, their support, and their relationship with healthcare.

Calculate my data scope →

Patient Journey Scope Estimator

01 — Disease areas

Which diseases are you targeting?

We structure patient conversations across 20+ diseases. The more specific you are, the sharper your scope.

02 — Target markets

Which countries are you targeting?

Every market is different. Your scope reflects your specific markets, not industry averages.

Select countries▼

03 — Your focus

What are you trying to understand?

Select all that apply to your launch objectives.

Understanding how patients navigate the diagnosis process

Making sense of how patients choose or switch treatments

Identifying unmet needs that current care is not addressing

Hearing what patients say beyond structured survey questions

Other

Mapping patient journeys…

Your scope summary

Patients in cohort

—

Data points

—

Min. interview time

—

Minimum coverage for a confident launch, based on data across 20+ disease areas and real patient cohorts.

Included in your scope

✓Diagnosis journey

✓Referral pathways

✓Treatment journey

✓Daily life impacts

✓Unmet needs

Ready to see this for your launch?

We'll walk you through patient intelligence for your disease areas and markets.

Book a call with our team →

Disease areas

Target markets

Your launch team is making decisions about patients they have never heard from.

Every function has a different view of the patient. mama health gives all teams one shared source of real patient intelligence — so launch decisions stop being built on assumptions.

Optimize launches on real patient behavior.

Understand why patients switch, delay, or drop off. Primary patient conversations surface the behavioral reasons behind every market signal — so your team can act, not just react.

Evidence the experience trial data doesn’t capture.

RWE tells you what was prescribed. It doesn’t tell you why patients stopped. mama health structures both — ready for evidence dossiers and advisory boards.

Test messaging on the people it’s for.

Brand teams test concepts on synthetic audiences — and find out months later patients heard something different. Close the loop in days with real cohort benchmarks.